Magnetic Resonance Imaging of Tumors with the Use of Iron Oxide Magnetic Nanoparticles as a Contrast Agent

Abstract

We studied the possibility of using BSA-coated magnetic iron oxide nanoparticles for magnetic resonance imaging diagnosis of C6 glioblastoma, 4T1 mammary adenocarcinoma, and RS-1 hepatic mucous carcinoma. In all three cases, magnetic nanoparticles accumulated in the tumor and its large vessels. Magnetic resonance imaging with contrast agent allows… (More)
DOI: 10.1007/s10517-017-3718-x

Topics

3 Figures and Tables

Cite this paper

@article{Semkina2017MagneticRI, title={Magnetic Resonance Imaging of Tumors with the Use of Iron Oxide Magnetic Nanoparticles as a Contrast Agent}, author={Antonina Semkina and Maxim A. Abakumov and Nadezhda F Grinenko and Alexey Lipengolts and Natalia V. Nukolova and Vladimir Pavlovich Chekhonin}, journal={Bulletin of Experimental Biology and Medicine}, year={2017}, volume={162}, pages={808-811} }